Soo Kun Lim

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour et al. · The Lancet Diabetes & Endocrinology · 2020 · 262 citations · Full text

Renal Function, Renal Disease, Crossover Trial +7

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Megumi Oshima, Meg Jardine, Rajiv Agarwal et al. · Kidney International · 2020 · 150 citations · Full text

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

Evidence for the detrimental role of proteolysis during liver preservation in humans

Yvon Calmus, Luc Cynober, B. Dousset et al. · Gastroenterology · 1995 · 85 citations

Hepatology, Biochemistry, Liver Physiology +14

Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease

Yoo Min Han, Hyuk Yoon, Soo Kun Lim et al. · Gut and Liver · 2017 · 80 citations · Full text